Top Markets
Coin of the day
Nanjing Hicin Pharmaceutical Co., Ltd. Nanjing Hicin Pharmaceutical Co., Ltd.

Nanjing Hicin Pharmaceutical Co., Ltd.

300584
Rang in Aktien #12879
Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and... Nanjing Hicin Pharmaceutical Co., Ltd. (NHPC), established in 2003 and headquartered in Nanjing, China, operates as a comprehensive enterprise specializing in the research, development, production, marketing, and distribution of pharmaceutical preparations and synthetic chemicals within China. The company boasts a diverse product portfolio, addressing various therapeutic areas such as antivirals, antibiotics, endocrine regulators, gastrointestinal treatments, orthopedic medications, cardiovascular and cerebrovascular drugs, and immunomodulatory agents. Beyond its core pharmaceutical activities, NHPC also provides technology transfer services. On an international scale, Nanjing Hicin Pharmaceutical Co., Ltd. is a supplier of Active Pharmaceutical Ingredients (APIs). Its export offerings specifically include injectable forms of omeprazole sodium and cefepime hydrochloride, along with lansoprazole tablets, which reach markets across South Asia, South America, and Europe.
Aktienkurs
$4.51
Marktkapitalisierung
$540.82M
Veränderung (1 Tag)
-2.42%
Veränderung (1 Jahr)
-43.50%
Land
CN
Handel Nanjing Hicin Pharmaceutical Co., Ltd. (300584)

Kategorie

Kursverlauf für Nanjing Hicin Pharmaceutical Co., Ltd. (300584)
Höchster Schlusskurs: $4.90 am 2026-08-01

Niedrigster Schlusskurs: $2.62 am 2017-01-01
Kursverlauf der Aktie von Nanjing Hicin Pharmaceutical Co., Ltd. von 2017 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -8.43%
2025 143.40%
2024 -11.77%
2023 -29.60%
2022 69.07%
2021 -18.98%
2020 -10.68%
2019 -0.37%
2018 22.24%
2017 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$165.71 30.94%
DE
$37.61 25.11%
JP
$219.53 25.89%
CH
$21.26 17.56%
IN